RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Wuhan Keqian Biology Co Stock

Wuhan Keqian Biology Co Revenue 2024

Wuhan Keqian Biology Co Revenue

1.27 B CNY

Ticker

688526.SS

ISIN

CNE1000042Q8

In 2024, Wuhan Keqian Biology Co's sales reached 1.27 B CNY, a 0.32% difference from the 1.26 B CNY sales recorded in the previous year.

The Wuhan Keqian Biology Co Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e1.6843,54
2025e1.4948,84
2024e1.2757,54
2023e1.2657,73
2022172,87
20211.179,74
20200.8482,57
20190.5178,86
20180.7484,28
20170.6384,42

Wuhan Keqian Biology Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Wuhan Keqian Biology Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Wuhan Keqian Biology Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Wuhan Keqian Biology Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Wuhan Keqian Biology Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Wuhan Keqian Biology Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Wuhan Keqian Biology Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Wuhan Keqian Biology Co’s growth potential.

Wuhan Keqian Biology Co Revenue, EBIT and net profit per share

DateWuhan Keqian Biology Co RevenueWuhan Keqian Biology Co EBITWuhan Keqian Biology Co Net Income
2026e1.68 B undefined0 undefined702.48 M undefined
2025e1.49 B undefined630.24 M undefined618.23 M undefined
2024e1.27 B undefined523.18 M undefined500.99 M undefined
2023e1.26 B undefined577.72 M undefined496.15 M undefined
20221 B undefined395.04 M undefined409.52 M undefined
20211.1 B undefined590.96 M undefined570.74 M undefined
2020843.2 M undefined487.4 M undefined447.8 M undefined
2019507.5 M undefined245.8 M undefined242.6 M undefined
2018735.3 M undefined425.3 M undefined389 M undefined
2017632.8 M undefined364.8 M undefined320.3 M undefined

Wuhan Keqian Biology Co stock margins

The Wuhan Keqian Biology Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Wuhan Keqian Biology Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Wuhan Keqian Biology Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Wuhan Keqian Biology Co's sales revenue. A higher gross margin percentage indicates that the Wuhan Keqian Biology Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Wuhan Keqian Biology Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Wuhan Keqian Biology Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Wuhan Keqian Biology Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Wuhan Keqian Biology Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Wuhan Keqian Biology Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Wuhan Keqian Biology Co Margin History

Wuhan Keqian Biology Co Gross marginWuhan Keqian Biology Co Profit marginWuhan Keqian Biology Co EBIT marginWuhan Keqian Biology Co Profit margin
2026e72.87 %0 %41.91 %
2025e72.87 %42.18 %41.38 %
2024e72.87 %41.26 %39.51 %
2023e72.87 %45.71 %39.25 %
202272.87 %39.45 %40.9 %
202179.74 %53.58 %51.74 %
202082.57 %57.8 %53.11 %
201978.86 %48.43 %47.8 %
201884.28 %57.84 %52.9 %
201784.42 %57.65 %50.62 %

Wuhan Keqian Biology Co Aktienanalyse

What does Wuhan Keqian Biology Co do?

Wuhan Keqian Biology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Wuhan Keqian Biology Co's Sales Figures

The sales figures of Wuhan Keqian Biology Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Wuhan Keqian Biology Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Wuhan Keqian Biology Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Wuhan Keqian Biology Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Wuhan Keqian Biology Co stock

How much revenue did Wuhan Keqian Biology Co generate this year?

Wuhan Keqian Biology Co has achieved a revenue of 1.27 B CNY this year.

How much was the turnover of the company Wuhan Keqian Biology Co compared to the previous year?

The revenue of Wuhan Keqian Biology Co has increased by 0.32% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Wuhan Keqian Biology Co?

The revenue of Wuhan Keqian Biology Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Wuhan Keqian Biology Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Wuhan Keqian Biology Co so important for investors?

The revenue of Wuhan Keqian Biology Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Wuhan Keqian Biology Co pay?

Over the past 12 months, Wuhan Keqian Biology Co paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.57 %. For the coming 12 months, Wuhan Keqian Biology Co is expected to pay a dividend of 0.21 CNY.

What is the dividend yield of Wuhan Keqian Biology Co?

The current dividend yield of Wuhan Keqian Biology Co is 1.57 %.

When does Wuhan Keqian Biology Co pay dividends?

Wuhan Keqian Biology Co pays a quarterly dividend. This is distributed in the months of July, June, July, June.

How secure is the dividend of Wuhan Keqian Biology Co?

Wuhan Keqian Biology Co paid dividends every year for the past 6 years.

What is the dividend of Wuhan Keqian Biology Co?

For the upcoming 12 months, dividends amounting to 0.21 CNY are expected. This corresponds to a dividend yield of 1.72 %.

In which sector is Wuhan Keqian Biology Co located?

Wuhan Keqian Biology Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Wuhan Keqian Biology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Wuhan Keqian Biology Co from 5/22/2024 amounting to 0.43 CNY, you needed to have the stock in your portfolio before the ex-date on 5/22/2024.

When did Wuhan Keqian Biology Co pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Wuhan Keqian Biology Co in the year 2023?

In the year 2023, Wuhan Keqian Biology Co distributed 0.19 CNY as dividends.

In which currency does Wuhan Keqian Biology Co pay out the dividend?

The dividends of Wuhan Keqian Biology Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Wuhan Keqian Biology Co

Our stock analysis for Wuhan Keqian Biology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wuhan Keqian Biology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.